Viewing Study NCT00853957


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2026-05-13 @ 11:51 AM
Study NCT ID: NCT00853957
Status: COMPLETED
Last Update Posted: 2012-04-30
First Post: 2009-02-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertension View
None African Americans View
None Aliskiren View
None Amlodipine View
None Systolic blood pressure View
None Diastolic blood pressure View
None Stage II View
None Combination View